Study Results

Start with A TREATMENT TARGETED FOR ROS1

People with ROS1+ non-small cell lung cancer can be treated with AUGTYRO as their first targeted therapy.

In a study of 71 people with ROS1+ lung cancer, they were given AUGTYRO as their first targeted therapy. They received AUGTYRO starting at 160 mg orally once daily for 14 days, and then their dose was increased to 160 mg twice daily until their doctor recommended otherwise.

Study-results Study-results

Possible side effects

Possible Side Effects to Look Out For

During treatment with AUGTYRO, side effects may occur. It’s important to be mindful, track changes, and assess how you’re feeling.

Rely on your care team

To have helpful conversations with them, remember to let your team know if you are experiencing any new or different symptoms at any time during your treatment.

AUGTYRO may cause serious side effects, including:

  • Central nervous system (CNS) effects
  • Lung problems (pneumonitis)
  • Liver problems
  • Muscle problems
  • Increased uric acid in your blood (hyperuricemia)
  • Bone fractures

The most common side effects of AUGTYRO include:

  • Dizziness
  • Change in sense of taste
  • Feeling of numbness or tingling in your arms or legs
  • Constipation
  • Trouble with balance, coordination, and walking
  • Shortness of breath
  • Problems with thinking, such as forgetfulness or confusion, memory problems and hallucinations
  • Tiredness
  • Nausea
Prescribing Information Patient Information

 

Important Facts
about AUGTYRO™ (repotrectinib)

This is a summary of important information that you need to know about AUGTYRO. Your healthcare team can work with you to help answer any questions you may have about this medication. Keep this document in a safe place, so you can refer to it before and during your treatment.

Look out for the following
icons as you read:

Talk to your healthcare team

Call a healthcare provider right away

Helpful information to remember

What is AUGTYRO?

AUGTYRO (repotrectinib) is an oral prescription medicine used to treat non-small cell lung cancer (NSCLC) in adults that:

  • Has spread within your chest or to other parts of the body, AND
  • Is caused by an abnormal ROS1 gene

It is not known if AUGTYRO is safe and effective in children.

  • Talk to your healthcare team for more information about what it means to have an abnormal ROS1 gene.

What is the most important information I should know about AUGTYRO?

AUGTYRO may cause serious side effects. A serious side effect is a side effect that can sometimes become life-threatening and can lead to death. The serious side effects of AUGTYRO may include:

Central nervous system (CNS) problems. Symptoms to look out for include:

  • dizziness
  • vertigo
  • changes in mood, such as anxiety,
    irritability, and depression
  • balance or coordination problems
  • problems with thinking, such as
    forgetfulness or confusion
  • seeing or hearing things that are not
    real (hallucinations)
  • problems with concentration,
    attention, memory, and sleep

Call your healthcare provider right away if you have any of these symptoms, or any worsening of CNS effects during treatment.

Lung problems (pneumonitis). AUGTYRO may cause pneumonitis (inflammation of the lungs), which may be severe or serious. New or worsening symptoms to look out for include:

  • Dry cough (without mucus)
  • Productive cough (with mucus)
  • Wheezing
  • Trouble breathing

Call your healthcare provider right away if you have any of these symptoms, or any worsening of your current lung problems.

Liver problems. Your healthcare provider will do blood tests to check your liver function before starting and during treatment with AUGTYRO. Symptoms of liver problems include:

  • your skin or the white part
    of your eyes turns yellow
  • dark or “tea-colored” urine
  • light-colored stools
    (bowel movements)
  • loss of appetite
  • nausea or vomiting
  • pain on the upper right side of your
    stomach area

Call your healthcare provider right away if you develop any of these symptoms of liver problems.

Muscle problems. Your healthcare provider will do blood tests before starting treatment with AUGTYRO, at least every 2 weeks for the first month and as needed during treatment. Symptoms of muscle problems include:

  • unexplained muscle pain or
    muscle pain that does not go away
  • tenderness
  • weakness

Call your healthcare provider right away if you get new or worsening signs and symptoms of muscle problems.

Increased uric acid level in your blood (hyperuricemia). AUGTYRO may cause an excess of uric acid in your blood. Your healthcare provider will do tests before and during your treatment with AUGTYRO to check the uric acid level in your blood. Your healthcare provider may prescribe medications if you have high blood uric acid levels. Tell your healthcare provider if you experience symptoms of increased uric acid including:

  • red, hot, tender, or swollen
    joints, especially in your big
    toe
  • pain in your stomach-area or
    sides
  • decrease in your amount
    of urine or no urine at all
  • nausea or vomiting
  • pink or brown urine or blood
    in your urine

Bone fractures. AUGTYRO may increase your risk for bone fractures. Bone fractures may happen with or without a fall or other injury.

Call your healthcare provider right away if you have pain, changes in movement, or bone abnormalities.

What should I discuss with my healthcare team before starting treatment?

Talk to your healthcare provider about all of your medical conditions, including if you:

  • have nervous system (neurological) problems
  • have lung or breathing problems other than lung cancer
  • have liver problems

Talk to your healthcare team about all the medicines you are taking, including:

  • prescription medicines
  • over-the-counter medicines
  • vitamins
  • herbal supplements

Certain other medicines may affect how AUGTYRO works, causing side effects.

These are not all the topics you should discuss with your healthcare team. Discuss any questions you may have with your healthcare team.

What should I discuss with my healthcare team about pregnancy, birth control, and breastfeeding before starting treatment?

Talk to your healthcare team if:

You are pregnant or plan to become pregnant — AUGTYRO may harm your unborn baby

If you are able to become pregnant, your healthcare team should do a pregnancy test before you start treatment with AUGTYRO.

If you are able to become pregnant, you should use effective non-hormonal birth control (contraception) during treatment and for 2 months after your last dose of AUGTYRO.

Birth control methods that contain hormones (such as birth control pills, injections or transdermal system patches) may not work as well during treatment with AUGTYRO.

Talk to your healthcare team about birth control methods that may be right for you.

Call your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with AUGTYRO.

You are a male with a female partner who is able to become pregnant

You should use effective birth control during treatment with AUGTYRO and for 4 months after your last dose.

Call your healthcare provider right away if your partner becomes pregnant during treatment with AUGTYRO.

You are breastfeeding or plan to breastfeed

Do not breastfeed during treatment and for 10 days after the last dose of AUGTYRO. It is not known if AUGTYRO passes into your breast milk. Talk to your healthcare team about the best way to feed your baby during this time.

What are the most common side effects of AUGTYRO?

The most common side effects of AUGTYRO include:

  • Dizziness
  • Change in sense of taste
  • Feeling of numbness or tingling in your arms or legs
  •  
  •  
  • Constipation
  • Trouble with balance, coordination, and walking
  • Shortness of breath
  • Problems with thinking, such as forgetfulness or confusion, memory problems and hallucinations
  • Tiredness
  • Nausea

These are not all of the possible side effects. Talk to your doctor for more information about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA by visiting www.fda.gov/medwatch or call 1-800-FDA-1088.

How should AUGTYRO be taken?

Take AUGTYRO exactly as your healthcare provider tells you. The number of pills that you take will depend on your dose. Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with AUGTYRO if you develop side effects. Do not change your dose or stop taking AUGTYRO without first talking to your healthcare provider.

pill-icon

AUGTYRO is a capsule with a white opaque cap and body, filled with a white to off-white powder. “REP 40” is printed in blue text on the cap.

Inactive ingredients: microcrystalline cellulose, sodium lauryl sulfate, croscarmellose sodium, and colloidal silicon dioxide.

Capsule coating inactive ingredients: gelatin and titanium dioxide.

Printing ink: shellac and FD & C blue #2 aluminum lake.

  • Do take AUGTYRO with or without food
  • Do take AUGTYRO at about the same time each day, such as in the morning or in the evening*
  • Do swallow AUGTYRO capsules whole with water.
  • *Setting an alarm clock or calendar notification is a great way to remember to take medication.
  • Do not open, crush, chew, or dissolve the capsule. Do not take broken, cracked, or damaged capsules
  • Do not eat grapefruit or drink grapefruit juice during treatment with AUGTYRO
  • Do not drive or operate machinery until you know how AUGTYRO affects you and you no longer have symptoms

What if I miss a dose of AUGTYRO?

If you miss a dose or vomit at any time after taking a dose of AUGTYRO, do not take an extra dose. Just skip the dose and take your next dose at the regularly scheduled time. Do not take 2 doses at the same time to make up a missed or vomited dose.

How do I store AUGTYRO?

AUGTYRO capsules should be stored at room temperature between 68°F to 77°F (20°C to 25°C).
Keep AUGTYRO and all medicines out of the reach of children.

For more information, please see U.S. Full Prescribing Information and Patient Information for AUGTYRO. Talk to your healthcare team for more information about this medication.